MARKER THERAPEUTICS, INC. (MRKR) Free cash flow 2017–2019
MARKER THERAPEUTICS, INC. (MRKR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.7MFY2019 · since FY2017: -$8.4M → -$18.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | -$18.7M | -27.6% |
| FY2018 | -$14.6M | -73.3% |
| FY2017 | -$8.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MRKR financial trends
MRKR RevenueMRKR Net incomeMRKR Net marginMRKR Gross profitMRKR Gross marginMRKR Operating incomeMRKR Operating marginMRKR Operating cash flowMRKR Capital expendituresMRKR Return on equityMRKR Stock buybacksMRKR Dividends paidMRKR Total assetsMRKR Total liabilitiesMRKR Shareholders’ equityMRKR overview →